|

Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer

RECRUITINGSponsored by Saint John's Cancer Institute
Actively Recruiting
SponsorSaint John's Cancer Institute
Started2018-10-03
Est. completion2028-10-03
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04603209

Summary

This is a prospective, registry study that will enroll all women with early stage breast cancer who will be treated with intraoperative radiotherapy (IORT) during breast-conserving surgery. The purpose of this study is to further validate the long-term effectiveness and safety of this treatment method. We aim to assess short and long-term patient outcomes associated with IORT, including perioperative complications, local and distance disease recurrences, as well as disease-free survival and overall survival.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Clinical stage Tis, T1, or T2(≤ 3cm), N0, M0 (AJCC Classification)
* Unifocal Disease
* Candidate for breast-conserving surgery
* Recommended treatment by multidisciplinary team

Exclusion Criteria:

* Clinical stage T3-4, N1-3, M1
* Multifocal disease

Conditions5

Breast CancerBreast Carcinoma in SituBreast NeoplasmsCancerEarly-stage Breast Cancer

Locations1 site

John Wayne Cancer Institute, Providence Saint John's Health Center
Santa Monica, California, 90404
Janie Grumley, MD310-582-7100janie.grumley@providence.org

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.